...
首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: The sildenafil and diastolic dysfunction after acute myocardial infarction (SIDAMI) trial
【24h】

Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: The sildenafil and diastolic dysfunction after acute myocardial infarction (SIDAMI) trial

机译:急性心肌梗死后Sildenafil和舒张性功能障碍在射血部分患者中:急性心肌梗死后的西地那非和舒张功能障碍(SIDAMI)试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Diastolic dysfunction is frequently seen after myocardial infarction and is characterized by a disproportionate increase in filling pressure during exercise to maintain stroke volume. We hypothesized that sildenafil would reduce filling pressure during exercise in patients with diastolic dysfunction after myocardial infarction. Methods and Results: Seventy patients with diastolic dysfunction and near normal left ventricular ejection fraction on echocardiography were randomly assigned sildenafil 40 mg thrice daily or matching placebo for 9 weeks. Before randomization and after 9 weeks of treatment patients underwent simultaneous echocardiography and right heart catheterization at rest and during exercise. Primary end point was pulmonary capillary wedge pressure, and secondary end points comprised cardiac index and pulmonary arterial pressure at rest and during exercise after 9 weeks. After 9 weeks there were no differences in pulmonary capillary wedge pressure at rest (13??4 versus 13??3 mm Hg, P=0.25) or at peak exercise (35??8 mm Hg versus 31??7 mm Hg, P=0.07). However, with treatment cardiac index increased at rest (P=0.006) and peak exercise (P=0.02) in the sildenafil group, and systemic vascular resistance index (resting, P=0.0002; peak exercise, P=0.007) and diastolic blood pressure (resting, P=0.005; peak exercise, P=0.02) were lower in the sildenafil group. Resting left ventricular end-diastolic volume index increased (P=0.001) within the sildenafil group but was unchanged in the placebo group. Conclusions: Sildenafil did not decrease filling pressure at rest or during exercise in post-myocardial infarction patients with diastolic dysfunction. However, there were effects on secondary end points, which require further studies. Clinical Trial Registration: URL: http://www.clinicaltrials. gov/ct2/show/NCT01046838. Unique identifier: NCT01046838. ? 2013 American Heart Association, Inc.
机译:背景:在心肌梗死后经常看到舒张性功能障碍,其特征在于运动期间填充压力的不成比例增加,以维持行程体积。我们假设西地那非将在心肌梗死后舒张性功能障碍患者的运动期间减少灌装压力。方法和结果:70例舒张功能障碍患者和超声心动图近常左心室喷射部分随机分配西地那非每日三分之一的30mg或匹配安慰剂9周。在随机化之前和9周后治疗患者在休息和运动期间接受同时超声心动图和右心导管。初级终点是肺毛细血管楔压力,次级端点在9周后休息和运动期间患有心脏指数和肺动脉压。 9周后,静止肺毛细血管楔压没有差异(13 ?? 4与13毫克,p = 0.25)或在峰锻炼(35μl8mm,31μmH≤7mmhg, p = 0.07)。然而,通过治疗心脏指数在Sildenafil组中静止(P = 0.006)和峰值运动(P = 0.02),以及全身血管阻力指数(休息,P = 0.0002;峰锻炼,P = 0.007)和舒张压(休息,P = 0.005; Sildenafil组中较低的峰值运动,P = 0.02)。休息左心室舒张性体积指数在西地那非组内增加(p = 0.001),但在安慰剂组中没有变化。结论:西地那非没有减少休息或运动患者在心肌梗死患者舒适症患者的舒适压力下降。然而,对次要终点的影响,需要进一步研究。临床试验注册:URL:http://www.clinictrials。 GOV / CT2 / SHOW / NCT01046838。唯一标识符:NCT01046838。还2013年美国心脏协会,Inc。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号